生命科学资讯

Janux sinks on ‘overreaction’ to prostate cancer data; RFK Jr. replaces ACIP chair

The ‘clever’ tool increasingly getting bigger biotech deals signed

UK agrees to boost drug prices to dodge US pharma tariffs

Regeneron inks gene editing deal with startup Tessera

Belite continues ascent as Stargardt drug hits mark in late-stage trial

With $130M, Protego pushes forward a new type of amyloidosis drug

Expanding access in oncology trials: The case for a paired tissue-plasma approach

Specialty pharmacy’s secret weapon: The unsung power of the enrollment form

From feedstocks to infrastructure, Indiana’s bioeconomy is on the move

Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3

Otsuka gains approval for first-of-its-kind treatment against rare kidney disease

CMS sets 2027 Medicare prices for Wegovy, Trelegy and 13 other drugs

Novartis wins approval to use SMA gene therapy in older patients

Gilead scoops up a preclinical cancer program

How do Big Pharma employees rate their CEOs?

Kelun, Merck tout ADC as potential first-line treatment in lung cancer

Bayer’s experimental blood-thinner notches trial win in stroke prevention

Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies

FDA probes effects of Takeda rare disease drug after patient death

Biogen strikes deal with Versant-backed biotech to expand immune portfolio